IP
HALO icon

Isthmus Partners’s Halozyme HALO Stock Holding History

Isthmus Partners’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$507K Buy
6,476
+505
+8% +$34.4K 0.05% 156
2026
Q1 		$386K Sell
5,971
-752
-11% -$53K 0.04% 159
2025
Q4 		$452K Sell
6,723
-121
-2% -$8.14K 0.05% 148
2025
Q3 		$502K Sell
6,844
-31
-0.5% -$2.06K 0.11% 75
2025
Q2 		$358K Hold
6,875
– – 0.04% 169
2025
Q1 		$439K Buy
6,875
+169
+3% +$9.82K 0.05% 149
2024
Q4 		$321K Buy
+6,706
New +$344K 0.04% 175

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Isthmus Partners's HALO Position: Q2 2026 in Review

Isthmus Partners increased its Halozyme (HALO) stake by 8.5% in Q2 2026, buying an estimated $34.4K and bringing the position to 6,476 shares worth $507K. The position accounts for 0.05% of the portfolio, ranked #156.

Isthmus Partners first reported a position in HALO in Q4 2024 and has held it in 7 quarters since. 673 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Isthmus Partners held 6,476 shares of Halozyme worth $507K as of Q2 2026.
  • Isthmus Partners bought 505 Halozyme shares in Q2 2026, an estimated $34.4K.
  • Halozyme made up 0.05% of Isthmus Partners's portfolio in Q2 2026, its #156 holding.
  • Isthmus Partners first reported a position in Halozyme in Q4 2024 and has held it in 7 quarters since.
  • 673 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Isthmus Partners's 13F filing for Q2 2026, filed 20 Jul 2026.